First trimester serum apolipoproteins in the prediction of late-onset preeclampsia

References

• World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. [Internet]. 2011. [cited 2020 Aug 16]. http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf
   Google Scholar
• Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.
   PubMed Web of Science ®Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC, International Society for the Study of Hypertension in Pregnancy (ISSHP), et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre‐eclampsia: a pragmatic guide for first‐trimester screening and prevention. Int J Gynecol Obstet. 2019;145(S1):1–33.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Rich-Edwards JW, McElrath TF, for the Global Pregnancy Collaboration, et al. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension. 2021;77(5):1430–1441.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med. 2012;25(5):498–507.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
   PubMed Web of Science ®Google Scholar
• Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.
   PubMed Web of Science ®Google Scholar
• Tan MY, Wright D, Syngelaki A, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE: first-trimester screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2018;51(6):743–750.
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am. J. Obstet. Gynecol. 2016;214(1):103.e1–103.e12.
   PubMed Web of Science ®Google Scholar
• Lan PG, Gillin AG, Pelosi M, et al. Effect of early use of low-dose aspirin therapy on late-onset preeclampsia. J. Matern. Fetal Neonatal Med. 2019;32(13):2137–2142.
   PubMed Web of Science ®Google Scholar
• Wright D, Nicolaides KH. Aspirin delays the development of preeclampsia. Am J Obstet Gynecol. 2019;220(6):580.e1-580–e6.
   Web of Science ®Google Scholar
• Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med. 2008;18(5):186–194.
   PubMed Web of Science ®Google Scholar
• Spracklen CN, Smith CJ, Saftlas AF, et al. Maternal hyperlipidemia and the risk of preeclampsia: a Meta-Analysis. Am J Epidemiol. 2014;180(4):346–358.
   PubMed Web of Science ®Google Scholar
• Serrano NC, Guio-Mahecha E, Quintero-Lesmes DC, et al. Lipid profile, plasma apolipoproteins, and pre-eclampsia risk in the GenPE case-control study. Atherosclerosis. 2018;276:189–194.
   PubMed Web of Science ®Google Scholar
• Timur H, Daglar HK, Kara O, et al. A study of serum apo A-1 and apo B-100 levels in women with preeclampsia. Pregnancy hypertens. Int J Womens Cardiovasc Health. 2016;6:121–125.
   Google Scholar
• Atkinson KR, Blumenstein M, Black MA, SCOPE Consortium, et al. An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia. J Lipid Res. 2009;50(1):71–80.
   PubMed Web of Science ®Google Scholar
• Mahley RW, Innerarity TL, Rall SC, et al. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25(12):1277–1294.
   PubMed Web of Science ®Google Scholar
• Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol. 2021;19(3):168–179.
   PubMed Web of Science ®Google Scholar
• Poon LCY, Zymeri NA, Zamprakou A, et al. Protocol for measurement of mean arterial pressure at 11-13 weeks’ gestation. Fetal Diagn Ther. 2012;31(1):42–48.
   PubMed Web of Science ®Google Scholar
• Ravnsborg T, Andersen LLT, Trabjerg ND, et al. First-trimester multimarker prediction of gestational diabetes mellitus using targeted mass spectrometry. Diabetologia. 2016;59(5):970–979.
   PubMed Web of Science ®Google Scholar
• Ravn JD, Bendix EJ, Sperling L, et al. First trimester serum matrix metalloproteinase-7 is a poor predictor of late-onset preeclampsia. Pregnancy Hypertens. 2022;28:94–99.
   PubMed Web of Science ®Google Scholar
• Rassart E, Desmarais F, Najyb O, et al. Apolipoprotein D. Gene. 2020;756:144874.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Ravnsborg T, Lohse Z, et al. Apolipoprotein D and transthyretin are reduced in female adolescent offspring of women with type 1 diabetes: the EPICOM study. Diabet Med. 2022;39(7):e14776. 10.1111/dme.14776
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:1–11.
   Google Scholar
• Crovetto F, Figueras F, Triunfo S, et al. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors: first trimester combined screening for early and late preeclampsia. Prenat Diagn. 2015;35(2):183–191.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim SH, Jung YW, et al. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. BMC Pregnancy Childbirth. 2014;14:35.
   PubMed Web of Science ®Google Scholar
• Cnossen JS, Vollebregt KC, Vrieze N D, et al. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ. 2008;336(7653):1117–1120.
   PubMed Web of Science ®Google Scholar
• Gasse C, Boutin A, Coté M, et al. First-trimester mean arterial blood pressure and the risk of preeclampsia: the great obstetrical syndromes (GOS) study. Pregnancy Hypertens. 2018;12:178–182.
   PubMed Web of Science ®Google Scholar
• Mosimann B, Amylidi-Mohr SK, Surbek D, et al. First trimester screening FOR preeclampsia – A systematic review. Hypertens Pregnancy. 2020;39(1):1–11.
   PubMed Web of Science ®Google Scholar
• Robillard P-Y, Dekker G, Scioscia M, et al. Increased BMI has a linear association with late-onset preeclampsia: a population-based study. Xie L, editor. Plos one. 2019;14:e0223888.
   Google Scholar
• Eastabrook G, Aksoy T, Bedell S, et al. Preeclampsia biomarkers: an assessment of maternal cardiometabolic health. Pregnancy Hypertens. 2018;13:204–213.
   PubMed Web of Science ®Google Scholar
• Panaitescu A, Ciobanu A, Syngelaki A, et al. Screening for pre-eclampsia at 35-37 weeks’ gestation: third-trimester screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2018;52(4):501–506.
   PubMed Web of Science ®Google Scholar
• Khan N, Andrade W, De Castro H, et al. Impact of new definitions of pre‐eclampsia on incidence and performance of first‐trimester screening. Ultrasound Obstet Gynecol. 2020;55(1):50–57.
   PubMed Web of Science ®Google Scholar
• Bouter AR, Duvekot JJ. Evaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia. Pregnancy Hypertens. 2020;19:206–211.
   PubMed Web of Science ®Google Scholar